Export-oriented focus sectors are likely to benefit, like the pharma and IT sectors. The consensus of experts is to maintain an investment horizon of 5-7 years and stick to allocation and diversify across large, mid and small-cap funds.
Rushabh Desai, Founder at Rupee With Rushabh Investment Service is bullish on four themes – banking & finance, consumption, pharma & healthcare and global technology. Domestic exposure to these themes can easily be taken care of by the flexi cap funds.
Flexi cap funds have very good exposure to banking and financial services, domestic technology, pharma & healthcare and consumption companies. He also stated that one can look at investing in Mirae Asset FANG Plus Fund for global technology exposure. Even Focused and Value/Contra Funds would also work well.
The IT sector will benefit the most because billings happen in dollars. However, some of the gains are being offset by cross-currency headwinds. Almost 50-60 percent of revenue comes from the Americas. The pharmaceutical sector is a net exporter and about 30 percent of total exports go to the US.